Correlation of patient skin doses in cardiac interventional radiology with dose-area product

The use of X-rays in cardiac interventional radiology has the potential to induce deterministic radiation effects on the patient's skin. Guidelines published by official organizations encourage the recording of information to evaluate this risk, and the use of reference values in terms of the dose-area product (DAP). Skin dose measurements were made with thermoluminescent dosemeters placed at eight different locations on the body. In addition, DAP was recorded in 100 patients for four types of interventional radiology procedures. Mean, median and third quartile for these results are presented. Maximum skin dose values found were 412 mGy, 725 mGy, 760 mGy and 1800 mGy for coronary catheterization, coronary catheterization with left ventricle investigation, and percutaneous transluminal angiography without and with stenting, respectively. Median DAPs for these same procedures were, respectively, 5682 cGy cm2, 10,632 cGy cm2, 10,880 cGy cm2 and 13,161 cGy cm2. The relationship between DAP and skin dose was investigated. We found a poor correlation of DAP with maximum skin dose (r = 0.77) and skin dose indicator (r = 0.78). Using conversion factors derived from Monte Carlo simulations, skin dose distributions were calculated based on the measured DAPs. Agreement between the calculated skin dose distribution, using DAP values averaged over a group of patients who underwent coronary catheterization and left ventricle investigation, and the measured skin dose averaged over the same group of patients was very good. However, there were large differences between the calculated skin doses using the individual DAP data per patient and measured skin doses for individual patients (r = 0.66). Hence, calculation of individual skin doses based on the specific DAP data per patient is not reliable and therefore measuring skin dose is preferable.     

Patient radiation doses and references levels in interventional radiology

PURPOSE: To set Diagnostic Reference Levels (DRLs) in interventional radiology by means of dose area product (DAP) measurements and the grouping of homogeneous procedures, and to quantify the associated errors in the DRL estimates. To evaluate the Mean Effective Doses per single procedure. MATERIALS AND METHODS: Interventional radiology procedures were divided into four main groups: neuroradiological, vascular, extravascular and paediatric. Neuroradiological and vascular procedures were further divided into diagnostic and interventional procedures. Starting from DAP and total fluoroscopy time measurements in 1,256 patients, the DRLs were determined for 17 procedures, together with an estimate of their uncertainty. The correlation between fluoroscopy time and DAP was assessed. Mean effective dose estimates were obtained from measured DAP values and from the analysis of the dosimetric data reported in the literature for similar procedures. RESULTS: The main features of DAP distributions are long high-dose tails, indicating asymmetric distributions, together with a large interquartile range. Rounded third-quartile values of DAP distributions showed a large range in the procedures taken into consideration. Values of 147, 198, 338 Gy cm(2)were obtained for supra-aortic angiography, cerebral angiography and embolization. Values of 86-101 and 459-438 Gy cm(2)were obtained for diagnostic and interventional vascular procedures on the lower limbs and on the abdomen, respectively. Values of 25-33 Gy cm(2)were obtained for retrograde cystourethrographies and ERCP, and values of 62-158 Gy cm(2)were obtained for nephrostomy and percutaneous transhepatic cholangiography. The correlation between total fluoroscopy time and the DAP values was poor. Mean effective dose estimates showed lower values for extravascular procedures (4.8-28.2 mSv), intermediate values for neuroradiological procedures (12.6-32.9 mSv) and higher values for vascular procedures involving the abdomen (36.5-86.8 mSv). DISCUSSION: DAP values were generally higher in vascular than in extravascular procedures. In generally, interventional vascular procedures show higher DAP values than the corresponding diagnostic procedures, with the exception of the abdominal region where the values were similar. Extravascular procedures with percutaneous access show significantly higher DAP values than those with endoscopic access. Total fluoroscopy time is a poor predictor of patient doses in interventional radiology. CONCLUSIONS: The systematic recording of DAP values, together with adequate grouping of similar procedures makes it possible to establish stable DRLs on a local basis and to carry out dosimetric evaluations, although on a statistical rather than individual basis. Patient radiation doses during interventional radiological procedures may be high, particularly when the abdominal region is involved.     

How to set up and apply reference levels in fluoroscopy at a national level

A nationwide survey was launched to investigate the use of fluoroscopy and establish national reference levels (RL) for dose-intensive procedures. The 2-year investigation covered five radiology and nine cardiology departments in public hospitals and private clinics, and focused on 12 examination types: 6 diagnostic and 6 interventional. A total of 1,000 examinations was registered. Information including the fluoroscopy time (T), the number of frames (N) and the dose-area product (DAP) was provided. The data set was used to establish the distributions of T, N and the DAP and the associated RL values. The examinations were pooled to improve the statistics. A wide variation in dose and image quality in fixed geometry was observed. As an example, the skin dose rate for abdominal examinations varied in the range of 10 to 45 mGy/min for comparable image quality. A wide variability was found for several types of examinations, mainly complex ones. DAP RLs of 210, 125, 80, 240, 440 and 110 Gy cm² were established for lower limb and iliac angiography, cerebral angiography, coronary angiography, biliary drainage and stenting, cerebral embolization and PTCA, respectively. The RL values established are compared to the data published in the literature.     

Occupational radiation exposure from fluoroscopically guided percutaneous transhepatic biliary procedures

PURPOSE: The aim of this study was to determine occupational dose levels for projections commonly used in fluoroscopically guided percutaneous transhepatic biliary (PTB) drainage and stent placement procedures. METHODS: Exposure data from 71 consecutive PTB examinations were analyzed to determine average examination parameters for biliary drainage and stent placement procedures. An anthropomorphic phantom was exposed at three projections common in PTB interventions according to the actual geometric parameters recorded in the patient study. Scattered air-kerma dose rates were measured for neck, waist, and gonad levels at various sites in the interventional radiology laboratory. To produce technique- and instrumentation-independent data, dose rate values were converted to dose-area product (DAP)-normalized air-kerma values. In addition, sets of thermoluminescent dosimetry crystals were placed in both hands of the interventional radiologist to monitor doses during all PTB procedures. RESULTS: Isodose maps of DAP-normalized air-kerma doses in the interventional laboratory for projections commonly used in PTB procedures are presented. To facilitate effective dose estimation, normalized dosimetric data at the interventional radiologist's position are presented for left and right access drainage procedures, metallic stent placement only, and drainage and metallic stent placement in one-session procedures with and without under-couch shielding. Doses to the hands of interventional radiologists are presented for left and right transhepatic biliary access and metallic stent placement. CONCLUSIONS: Body level-specific normalized air-kerma distributions from commonly used projections in PTB procedures may be useful to accurately quantify dose, maximum workloads, and possible radiogenic risks delivered to medical personnel working in the interventional radiology laboratory. Normalized dose data presented will enable occupational exposure estimation from other institutions.     

A study on radiation doses and irradiated areas in cerebral embolisation

Patient radiation doses during interventional radiology procedures may reach the thresholds for radiation-induced skin and eye lens injuries. This study investigates the irradiated areas and doses received by patients undergoing cerebral embolisation, which is regarded as a high dose interventional radiology procedure. For each procedure the fluoroscopic and digital dose-area product (DAP), the fluoroscopic time, the total number of acquired images and entrance-skin dose (ESD) calculated by the angiographic unit were recorded. The ESD was measured by means of thermoluminescent dosimeters. In this study, the skin, eye and thyroid gland doses and the irradiated area for 30 patients were recorded. The average ESD was found to be 0.77 Gy for the posteroanterior plane and 0.78 Gy for the lateral plane. The average DAP was 48 Gy cm(2) for the posteroanterior plane and 58 Gy cm(2) for the lateral plane. The patient's average right eye dose was 60 mGy and the dose to the thyroid gland was 24 mGy. Seven patients received a dose above 1 Gy, one patient exceeded the threshold for transient erythema and one exceeded the threshold for temporary epilation. A good correlation between the DAP and the ESD for both planes has been found. The doctor's eye dose has also been measured for 17 procedures and the average dose per procedure was 0.13 mGy.     

Calculating effective dose on a cone beam computed tomography device: 3D Accuitomo and 3D Accuitomo FPD

OBJECTIVES: This study evaluates two methods for calculating effective dose, CT dose index (CTDI) and dose-area product (DAP) for a cone beam CT (CBCT) device: 3D Accuitomo at field size 30x40 mm and 3D Accuitomo FPD at field sizes 40x40 mm and 60x60 mm. Furthermore, the effective dose of three commonly used examinations in dental radiology was determined. METHODS: CTDI(100) measurements were performed in a CT head dose phantom with a pencil ionization chamber connected to an electrometer. The rotation centre was placed in the centre of the phantom and also, to simulate a patient examination, in the upper left cuspid region. The DAP value was determined with a plane-parallel transmission ionization chamber connected to an electrometer. A conversion factor of 0.08 mSv per Gy cm(2) was used to determine the effective dose from DAP values. Based on data from 90 patient examinations, DAP and effective dose were determined. RESULTS: CTDI(100) measurements showed an asymmetric dose distribution in the phantom when simulating a patient examination. Hence a correct value of CTDI(w) could not be calculated. The DAP value increased with higher tube current and tube voltage values. The DAP value was also proportional to the field size. The effective dose was found to be 11-77 microSv for the specific examinations. CONCLUSIONS: DAP measurement was found to be the best method for determining effective dose for the Accuitomo. Determination of specific conversion factors in dental radiology must, however, be further developed.     

Estimation of the effective dose of patient in interventional radiology: study of coronary angiography

The applications of interventional radiology (IVR) increasingly are being used in clinical examinations, where they tend to extend examination time. In addition, the risk of occupational exposure necessarily is increasing with this technology. In this study, the dose distributions in a sliced acrylic-acid phantom involving the bore for each irradiation condition were measured using a thermoluminescence dosimeter (TLD). Four patterns of set-up for the fluoroscopy unit were chosen as references for the conditions generally used clinically. Exposure also was measured with dose area product (DAP), and we then calculated the entrance skin dose and effective dose for the patient. The results showed that the effective dose was 7.0 mSv to 8.0 mSv at LAO45 degrees and RAO30 degrees; 100 kV, 2.3 mSv to 3.3 mSv at LAO45 degrees and RAO30 degrees; 80 kV. The effective dose is greatly influenced by the setup of fluoroscopy in IVR. The change in DAP is especially influenced. We found that the relation between DAP and effective dose was corrected with the exponential function. The effective doses were not necessarily less than those of other radiation examinations, and increase. When PCI and TAE are repeated many times in IVR, we propose that the effective dose should be taken into consideration together with the skin dose for dose control management.     

Comparison of effective doses obtained from dose-area product and air kerma measurements in interventional radiology

In this study, measurements of dose-area product (DAP) and entrance dose were carried out simultaneously in a sample of 162 adult patients who underwent different interventional examinations. Effective doses for each measurement technique were estimated using the conversion factors that have been determined for specific X-ray views in a mathematical phantom. Exposure conditions used in clinical practice never match these theoretical models exactly, and deviations from the assumed standard conditions cause uncertainties in effective dose estimations. Higher effective dose values are found if the air kerma results are used rather than DAP readings, both for patient and Rando phantom studies. Comparison of DAP, fluoroscopy times and skin doses were made with published data. DAP measurement for the effective dose calculation and thermoluminescent dosimeter for the skin dose estimates are found to be the most reliable methods for patient dosimetry.     

Evaluation of patient doses in interventional radiology]

PURPOSE: To verify the suitability of indicative quantities to evaluate the risk related to patient exposure, in abdominal and vascular interventional radiology, by the study of correlations between dosimetric quantities and other indicators. MATERIAL AND METHODS: We performed in vivo measurements of entrance skin dose (ESD) and dose area product (DAP) during 48 procedures to evaluate the correlation among dosimetric quantities, and an estimation of spatial distribution of exposure and effective dose (E). To measure DAP we used a transmission ionization chamber and to evaluate ESD and its spatial distribution we used radiographic film packed in a single envelope and placed near the patient's skin. E was estimated by a calculation software using data from film digitalisation. RESULTS: From the data derived for measurements in 27 interventional procedures on 48 patients we obtained a DAP to E conversion factor of 0.15 mSv / Gy cm2, with an excellent correlation (r=.99). We also found a good correlation between DAP and exposure parameters such as fluoroscopy time and number of images. The greatest effective dose was evaluated for a multiple procedure in the hepatic region, with a DAP value of 425 Gy cm2. The greatest ESD was about 550 mGy. For groups of patients undergoing similar interventional procedures the correlation between ESD and DAP had conversion factors from 6 to 12 mGy Gy-1 cm-2. CONCLUSION: The evaluation of ESD and E by slow films represents a valid method for patient dosimetry in interventional radiology. The good correlation between DAP and fluoroscopy time and number of images confirm the suitability of these indicators as basic dosimetric information. All the ESD values found are lower than threshold doses for deterministic effects.     

Patient and occupational dosimetry in double contrast barium enema examinations

A new and relatively simple method is presented to distribute total dose-area product (DAP) over a number of projections that model exposure during double contrast barium enema (DCBE) examinations. In addition, hitherto unavailable entrance and effective doses to the physician performing the DCBE examination have been determined. DAP, fluoroscopy time, number of images as well as some patient data were collected for 150 DCBE examinations. For a subset of 50 examinations, the distribution of DAP over 12 hypothetical but representative projections was estimated by measuring the entrance dose in the centre of each of these projections during the complete procedure. Effective dose to the patient was obtained using DAP to effective dose conversion coefficients calculated for each of the 12 projections. Exposure of the worker was quantified by measuring the entrance dose at the forehead, neck, arms, right hand and legs. The sex-averaged effective dose to the patient per examination was 6.4+/-2.1 mSv (mean+/-SD; n=50) and the corresponding DAP was 44+/-22 Gy cm(2). The effective dose to the worker per examination was 0.52 microGy (n=50), whereas the highest entrance dose of 30+/-25 microGy was found for the right arm. The proposed method for deriving the distribution of total DAP over a set of representative projections is much less time consuming than visual observation of patient exposure, whilst accuracy seems acceptable. Entrance and effective doses per examination for workers in DCBE examinations are very low. For a normal workload, doses remain far below the legally established dose limits.     

Estimation of operator dose by dose area product meter

Because of the more advanced and more complex procedures in interventional radiology (IVR), longer treatment times have become necessary. Therefore, it is important to determine the exposure doses received by operators and patients. Operator doses arising from the use of X-rays are mainly due to scattered radiation. The purpose of this study was to assess the feasibility of estimating operator dose by dose area product (DAP), which shows the total X-ray output from the collimator. DAP showed a strong correlation with the space dose from the fundamental examination. In clinical practice, we measured the exposure doses of the neck, left shoulder, left hand, and right finger using a thermoluminescence dosimeter (TLD). These then were compared with the DAP. The results indicated that the dose equivalents (H70 microm) of the neck and left shoulder were strongly correlated with DAP (r=0.85, 0.86), whereas the H70 microm of the left hand and right finger were less closely correlated (r=0.40, 0.48). In comparison with the fluoroscopic time, the dose equivalents showed a better correlation with DAP in all the evaluated parts. The effective doses for the operator were strongly correlated with DAP (r=0.87). When measurements are not available, dose equivalents and operator effective doses can be estimated by the DAP, as indicated by the strong correlations recognized in this study.     

Variations of Patient Doses in Interventional Examinations at Different Angiographic Units

Purpose We analyzed doses for various angiographic procedures using different X-ray systems in order to assess dose variations. Methods Dose-area product (DAP), skin doses from thermoluminescent dosimeters and air kerma measurements of 308 patients (239 diagnostic and 69 interventional) were assessed for five different angiographic units. All fluoroscopic and radiographic exposure parameters were recorded online for single and multiprojection studies. Radiation outputs of each X-ray system were also measured for all the modes of exposure using standard protocols for such measurements. Results In general, the complexity of the angiographic procedure was found to be the most important reason for high radiation doses. Skill of the radiologist, management of the exposure parameters and calibration of the system are the other factors to be considered. Lateral cerebral interventional studies carry the highest risk for deterministic effects on the lens of the eye. Effective doses were calculated from DAP measurements and maximum fatal cancer risk factors were found for carotid studies. Conclusions Interventional radiologists should measure patient doses for their examinations. If there is a lack of necessary instrumentation for this purpose, then published dose reports should be used in order to predict the dose levels from some of the exposure parameters. Patient dose information should include not only the measured quantity but also the measured radiation output of the X-ray unit and exposure parameters used during radiographic and fluoroscopic exposures.     

Effective doses in angiography and interventional radiology: calculation of conversion coefficients for angiography of the lower limbs

The present study reports on investigations that we have performed to allow the calculation of effective doses (E) in interventional radiology. The use of published conversion tables might not allow sufficient guidance for the establishment of optimization strategies for procedures in interventional radiology. With the Monte Carlo N-Particle transport code (MCNP4B), conversion coefficients, linking dose-area product (DAP) measurements with E, are calculated for angiography of the lower limbs in six hospitals. The influence of various parameters on the calculation of these conversion coefficients is studied in a systematic way using the 2(n) factorial design. In this design the effect of different parameters and their pair-wise interactions on a certain variable is explored. In our study, the relevant parameters are tube potential, total filtration and field size and position. We concluded that the influence of radiation spectrum (kVp + filtration) is large and that the effect of field position and size is moderate, except when differences are observed in respect of the gonads. In that case, the variation in conversion coefficients is large. The results of this statistical analysis are then applied to the differences observed between the conversion coefficients, calculated for angiography of the lower limbs in the six hospitals. Recommendations for optimization of patient doses are given.     

Radiation exposure to cardiologists performing interventional cardiology procedures

Medical doctors, who practice interventional cardiology, receive a noticeable radiation dose. In this study, we measured the radiation dose to 9 cardiologists during 144 procedures (72 coronary angiographies and 70 percutaneus translumined coronary angioplasties) in two Greek hospitals. Absorbed doses were measured with TLD placed underneath and over the lead apron at the thyroid protective collar. Based on these measurements, the effective dose was calculated using the Niklason method. In addition, dose area product (DAP) was registered. The effective doses, E, were normalised to the total DAP measured in each procedure, producing the E/DAP index. The mean effective dose values were found to be in the range of 1.2-2.7 microSv while the mean E/DAP values are in the range of 0.010-0.035 microSv/Gycm2. The dependence of dose to the X-ray equipment, the exposure parameters and the technique of the cardiologist were examined. Taking under consideration the laboratories' annual workload, the maximum annual dose was estimated to be 1.9 and 2.8 mSv in the two hospitals.     

Staff Radiation Doses to the Lower Extremities in Interventional Radiology

The purpose of this study was to investigate the radiation doses to the lower extremities in interventional radiology suites and evaluate the benefit of installation of protective lead shielding. After an alarmingly increased dose to the lower extremity in a preliminary study, nine interventional radiologists wore thermoluminescent dosimeters (TLDs) just above the ankle, over a 4-week period. Two different interventional suites were used with Siemens undercouch fluoroscopy systems. A range of procedures was carried out including angiography, embolization, venous access, drainages, and biopsies. A second identical 4-week study was then performed after the installation of a 0.25-mm lead curtain on the working side of each interventional table. Equivalent doses for all nine radiologists were calculated. One radiologist exceeded the monthly dose limit for a Category B worker (12.5 mSv) for both lower extremities before lead shield placement but not afterward. The averages of both lower extremities showed a statistically significant dose reduction of 64% (p < 0.004) after shield placement. The left lower extremity received a higher dose than the right, 6.49 vs. 4.57 mSv, an increase by a factor of 1.42. Interventional radiology is here to stay but the benefits of interventional radiology should never distract us from the important issue of radiation protection. All possible measures should be taken to optimize working conditions for staff. This study showed a significant lower limb extremity dose reduction with the use of a protective lead curtain. This curtain should be used routinely on all C-arm interventional radiologic equipment.     

An investigation into patient and staff doses from X-ray angiography during coronary interventional procedures

Radiation doses to patients from interventional coronary X-ray procedures are relatively high when compared with conventional radiographic procedures. These high patient doses can translate into high staff doses owing to scattered radiation. This study investigates patient doses by means of dose-area product (DAP) meters installed in six rooms in two hospitals. DAP measurements in each room ranged from 28.0-39.3 Gy cm2 for coronary angiography and from 61.3-92.8 Gy cm2 for percutaneous transluminal coronary angioplasty, with the mean effective doses calculated to range between 5.1-6.6 mSv and 11.2-17.0 mSv, respectively. These values are comparable with those found in recent literature. DAP measurements were found to correlate strongly (correlation coefficient of 79%) with patient weight. The non-uniform scatter radiation fields surrounding the irradiated area during coronary angiography were also investigated using a tissue equivalent phantom and an ionization chamber. Exposure rates of scattered radiation from digital acquisition were found to be around 16 times higher than those generated from fluoroscopy, and oblique-angled imaging led to greater amounts of scatter owing to the increase in related exposure factors. The distribution of scatter from oblique projections confirms that X-ray photons in the diagnostic energy range are preferentially scattered backwards, toward the X-ray tube. These concepts are a major consideration when training individuals working in the angiography suite in order to keep doses "as low as reasonably practicable".     

Entrance skin dose estimates derived from dose-area product measurements in interventional radiological procedures.

Patient skin doses resulting from interventional radiological procedures have the potential to exceed threshold doses for deterministic effects such as erythema and epilation. If the irradiation geometry is known, the entrance skin dose can be estimated from the measured dose-area product. For each of 10 non-coronary interventional procedures, a nominal geometry was identified. From a previous survey of patient dose-area products, the entrance skin doses were estimated under the assumption that all procedures were performed with the nominal geometry specific to it. An analysis of the uncertainties in these doses caused by realistic deviations from the nominal geometry was also performed and it was shown that the estimated entrance skin dose values are at least to within 40%, and generally to within about 30%, of those actually received. For example, the median estimated entrance skin doses for the posteroanterior and lateral projections of cerebral angiography were 100 and 110 mGy. respectively, and for hepatic angiography 425 mGy. The largest entrance skin dose estimate for a single projection was for the angiography component of a CT arterial portography procedure at 670 mGy. Comparisons between entrance skin dose estimates obtained from this study are made with data from other interventional radiology patient dose surveys.     

平板DSA介入检查治疗患者的剂量调查

目的 调查平板数字减影血管造影(DSA)介入检查治疗患者的照射剂量,分析影响患者照射剂量的因素.方法 收集2009年3至6月来本院做DSA检查治疗的患者461例,手术种类包括全脑血管造影(CEA)、颅内动脉瘤弹簧圈栓塞(CAE)、肝脏动脉造影+超选化疗(SHAC)、冠状动脉造影(COA)、冠状动脉支架植入(PISI)、心脏射频消融(RFCA)、永久起搏器安装(PCPI).通过采集所有病例的剂量面积值(DAP)、累计皮肤表面人射剂量(CAK)、透视时间,采用转换因子计算有效剂量值.结果 CEA、CAE、SHAC、COA、PIST、RFCA、PCPI的有效剂量当量分别为(0.33±0.20)、(0.49±0.35)、(6.92±4.19)、(0.76±0.91)、(2.35±1.47)、(0.50±0.74)和(0.67±0.70)Sv;461例患者中超过1 Sv的达到120人次,占26%,超过10 Sv的达到10人次,均为SHAC患者.CAK分另为(0.55±0.43)、(1.34±1.11)、(0.95±0.57)、(0.32±0.31)、(0.91±0.33)、(0.16±0.22)和(0.15±0.14)Gy,CAK值超过1 Gy共为59例,占12.8%,超过2 Gy为11例,占2.4%,有2例超过3 Gy,为4.5和6.1 Gy,分别为CEA和CAE患者.结论 各项介入手术患者所受照射剂量个体差异较大.介入检查治疗患者接受的照射剂量较高,需要进行严格的监督以保证患者照射剂量得到最佳控制.

Abstract：

Objective To investigate the radiation doses for the patients undergoing interventional radiology and to analyze the dose - influencing factors.MethodsThe clinical data of 461 patients undergoing interventional radiology,including cerebral angiography ( CEA ),cerebral aneurysm embolism ( CAE ),superselective hepatic arterial chemoembolization ( SHAG ),coronary angiography ( COA ),percutaneous intracoronary stent implantation ( PIS1 ),cardiac radiofrequency catheter ablation ( RFCA ),and permanent cardiac pacemaker implantation(PCPI) were collected to observe the cumulative air kerma (CAK),dose area product (DAP),and fluoroscopy time,and effective dose was estimated using the conversion factors.Results The effective doses for CEA,CAE,SHAG,COA,PISI,RFCA,and PCPI were (0.33 ±0.20),(0.49 ±0.35),(6.92 ±4.19),(0.76 ±0.91),(2.35 ± 1.47),(0.50 ±0.74),and (0.67 ±0.70) Sv,respectively.In 126 of the 416 patients (26%),the effective doses were greater than 1 Sv,and the effective doses of 10 person-times were greater than 10 Sv,all of which were observed in the patients undergoing SHAG.The CAK values for CEA,CAE,SHAG,COA,PISI,RFCA,and PCPIwere (0.55 ±0.43),(1.34 ± 1.11),(0.95 ±0.57),(0.32 ±0.31),(0.91 ±0.33),(0.16 ±0.22),and (0.15 ±0.14) Gy,respectively.The CAK values were greater than 1 Gy in 59 of the 461 patients ( 12.8% ),greater than 2 Gy in 11 cases (2.4%) ,and greater than 3 Gy in 1 CEA cases and 1 CEA case,respectively.Conclusions There is a wide variation range in radiation dose for different procedures.As most interventional radiology procedure can result in clinically significant radiation dose to the patient,stricter dose control should be carried out.     

Dose and image quality in the comparison of analogue and digital techniques in paediatric urology examinations

In paediatric radiology it has been recognised that children have a higher risk of developing cancer from the irradiation than adults (two to three times); therefore, increased attention has been directed towards the dose to the patient. In this study the effect on patient dose and image quality in replacing the exposure in micturating cystourethrography (MCUG) examinations with the stored fluoroscopy image has been investigated. In the intravenous urography (IVU) examination we compared analogue and digital image quality, but the dose measurements were performed on a phantom. Standard clinical X-ray equipment was used. Sixty-eight patients in each of two centres were studied for the MCUG. Doses were measured with a dose-area product (DAP) meter and the image quality was scored. A non-parametric statistical analysis was performed. For the IVU, a phantom was used in the dose measurements but clinical images were scored in the comparison between analogue and digital images. For the MCUG, replacing the exposure with stored fluoroscopy images lowered the DAP value from 0.77 to 0.50 Gy cm². The image quality did not show any difference between the techniques; however, if reflux was to be graded, exposure was needed. For the IVU, the doses could be lowered by a factor of 3 using digital techniques. The image quality showed no statistical difference between the two techniques. There is a potential for a substantial dose reduction in both MUCG and IVU examinations using digital techniques.     

National reference doses for common radiographic, fluoroscopic and dental X-ray examinations in the UK

The National Patient Dose Database (NPDD) is maintained by the Radiation Protection Division of the Health Protection Agency. The latest review of the database analysed the data collected from 316 hospitals over a 5-year period to the end of 2005. The information supplied amounted to a total of 23 000 entrance surface dose measurements and 57 000 dose-area product measurements for single radiographs, and 208 000 dose-area product measurements along with 187 000 fluoroscopy times for diagnostic examinations or interventional procedures. In addition, patient dose data for dental X-ray examinations were included for the first time in the series of 5-yearly reviews. This article presents a summary of a key output from the NPDD - national reference doses. These are based on the third quartile values of the dose distributions for 30 types of diagnostic X-ray examination and 8 types of interventional procedure on adults, and for 4 types of X-ray examination on children. The reference doses are approximately 16% lower than the corresponding values in the previous (2000) review, and are typically less than half the values of the original UK national reference doses that were derived from a survey in the mid-1980s. This commentary suggests that two of the national reference doses from the 2000 review be retained as diagnostic reference levels because the older sample size was larger than for the 2005 review. No clear evidence could be found for the use of digital imaging equipment having a significant effect on dose.